Value Based Healthcare and Implications IT

Value Based Healthcare and Implications IT

January 14, 2021
January 14, 2021

Share

The Transition to a Value-Based Healthcare System and Implications for Healthcare IT Vendors

The U.S. healthcare system is currently in the midst of transitioning towards a value-based reimbursement model (compensating providers based on patient outcomes rather than services provided), presenting a significant opportunity for technology and service vendors aiding in that transition. What are the trends, why are healthcare providers willing to invest, and who is to benefit?


There is a Long-Running Trend Toward Value-Based Care
  • The American Healthcare system has historically been dominated by Fee-for-Services (FFS) reimbursement models, which compensate healthcare providers for services offered rather than on patient outcomes.
  • Over the last ~10-12 years, the healthcare system has begun to transition from FFS-dominant to value-based, where both public insurance plans and commercial payers consider the outcome and quality of care provided when determining reimbursement amounts.
  • This transition is currently in the early stages today, with many different models for value-based systems in the process of being tested and evaluated.


Healthcare Providers are Willing to Invest in Value-Based Care Tools
  • Healthcare providers have demonstrated a significant willingness to spend on solutions that help them implement value-based care models.
  • Solutions that help providers reduce costs, increase efficiency, and mitigate risks while improving patient outcomes are highly attractive, as value-based care models drive providers to become hyper-focused on their practices.
  • Hospitals, in particular, have demonstrated a significant willingness to invest in partnerships that can help reduce patient readmissions within 30 days (and the attending reimbursement penalties). For example, some hospitals have contracted with home health providers to proactively treat at-risk patients and prevent ER visits, with contracts more profitable to the home health agency via hospital bonus payments than their own patient reimbursement contracts.


Technology and Service Offerings That Support Value-Based Workflows Stand to Benefit
  • Technology and service offerings that are able to aid providers in the shift to value-based care models and that contribute directly to provider profitability are highly likely to see significant growth moving forward.
  • Tools such as physician scorecards, adaptive training modules, modules to integrate health data and predict care requirements, and EHR integrations supporting interoperability between healthcare providers are all areas that are likely to see direct benefits as a result of the transition to value-based care.


Read More

A Recap: Investing in Behavioral Health—Scalable Solutions for a Growing Need
July 14, 2025
Stax hosted healthcare-focused PE professionals in NYC to discuss a range of topics including scalable, tech-enabled behavioral health investments amid evolving care models and reimbursement. Click to learn more about what this event covered and how you can learn more.
Stax Perspective: AI Tools for K-12 Education
By Miriam El-Baz July 9, 2025
With AI education now a national priority, Miriam El-Baz highlights in her latest article how investor focus is shifting to classroom adoption and long-term, responsible impact. Learn more.
Stax Provides Sell-side Support to Bow River Capital on its Sale of Progressive Roofing to TopBuild
July 8, 2025
Stax congratulates Bow River Capital on the successful sale of Progressive Roofing, provider commercial roofing installation services, to TopBuild. Click here to read more.
A Plan in Need of a Plan—Early Reflections on the New 10-Year Plan for the NHS
By Adam Thorpe July 4, 2025
Following the release of the NHS 10-Year Plan yesterday, Stax explores what it means for independent sector providers and healthcare investors. Read more.
Featured by Reuters: How China's new auto giants left GM, VW and Tesla in the dust
By Phil Dunne July 3, 2025
In this recent Reuters special report, Phil Dunne highlights why automakers struggle to match Chinese carmakers—but still hold key advantages, especially in Europe. Click here to read more.
Featured by Carta: Tariffs bring uncertainty—and opportunities—for PE and M&A
By Robert Lytle July 2, 2025
Senior Managing Director Robert Lytle was featured by Carta in their latest article, discussing the impacts of tariffs on M&A and portfolio companies. Click here to read more.
Show More